nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCB1—esophageal cancer	0.276	1	CbGaD
Nelfinavir—ABCG2—Carboplatin—esophageal cancer	0.0853	0.169	CbGbCtD
Nelfinavir—ABCG2—Cisplatin—esophageal cancer	0.0729	0.145	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—esophageal cancer	0.0632	0.125	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—esophageal cancer	0.0596	0.118	CbGbCtD
Nelfinavir—CYP2C9—Capecitabine—esophageal cancer	0.0538	0.107	CbGbCtD
Nelfinavir—CYP2B6—Cisplatin—esophageal cancer	0.0513	0.102	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—esophageal cancer	0.0473	0.0939	CbGbCtD
Nelfinavir—CYP2C9—Cisplatin—esophageal cancer	0.0271	0.0538	CbGbCtD
Nelfinavir—ABCB1—Cisplatin—esophageal cancer	0.0263	0.0522	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—esophageal cancer	0.0171	0.0339	CbGbCtD
Nelfinavir—Indinavir—ABCC2—esophageal cancer	0.0021	0.419	CrCbGaD
Nelfinavir—Amylase increased—Cisplatin—esophageal cancer	0.00202	0.0291	CcSEcCtD
Nelfinavir—Saquinavir—ABCC2—esophageal cancer	0.00157	0.312	CrCbGaD
Nelfinavir—Opportunistic infection—Methotrexate—esophageal cancer	0.00131	0.0189	CcSEcCtD
Nelfinavir—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.00123	0.0178	CcSEcCtD
Nelfinavir—Blood triglycerides increased—Capecitabine—esophageal cancer	0.00108	0.0156	CcSEcCtD
Nelfinavir—Hyperuricaemia—Cisplatin—esophageal cancer	0.00104	0.0149	CcSEcCtD
Nelfinavir—Haemoglobin decreased—Capecitabine—esophageal cancer	0.00103	0.0148	CcSEcCtD
Nelfinavir—Torsade de pointes—Capecitabine—esophageal cancer	0.00101	0.0146	CcSEcCtD
Nelfinavir—Pain—Carboplatin—esophageal cancer	0.000999	0.0144	CcSEcCtD
Nelfinavir—Blood uric acid increased—Cisplatin—esophageal cancer	0.000978	0.0141	CcSEcCtD
Nelfinavir—Body temperature increased—Carboplatin—esophageal cancer	0.000924	0.0133	CcSEcCtD
Nelfinavir—Folliculitis—Methotrexate—esophageal cancer	0.000839	0.0121	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000779	0.0112	CcSEcCtD
Nelfinavir—Indinavir—ABCB1—esophageal cancer	0.000774	0.154	CrCbGaD
Nelfinavir—Inflammation—Capecitabine—esophageal cancer	0.00073	0.0105	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000697	0.0101	CcSEcCtD
Nelfinavir—Dehydration—Cisplatin—esophageal cancer	0.000649	0.00936	CcSEcCtD
Nelfinavir—Mouth ulceration—Capecitabine—esophageal cancer	0.00064	0.00924	CcSEcCtD
Nelfinavir—Cramp muscle—Cisplatin—esophageal cancer	0.000628	0.00906	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000628	0.00906	CcSEcCtD
Nelfinavir—Sleep disorder—Capecitabine—esophageal cancer	0.000594	0.00857	CcSEcCtD
Nelfinavir—Diabetes mellitus—Capecitabine—esophageal cancer	0.000591	0.00853	CcSEcCtD
Nelfinavir—Pancreatitis—Cisplatin—esophageal cancer	0.000591	0.00853	CcSEcCtD
Nelfinavir—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00058	0.00836	CcSEcCtD
Nelfinavir—Saquinavir—ABCB1—esophageal cancer	0.000578	0.115	CrCbGaD
Nelfinavir—Hyperuricaemia—Methotrexate—esophageal cancer	0.000568	0.0082	CcSEcCtD
Nelfinavir—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000557	0.00804	CcSEcCtD
Nelfinavir—Inflammation—Methotrexate—esophageal cancer	0.000544	0.00784	CcSEcCtD
Nelfinavir—Dermatitis bullous—Capecitabine—esophageal cancer	0.000538	0.00776	CcSEcCtD
Nelfinavir—Blood uric acid increased—Methotrexate—esophageal cancer	0.000537	0.00775	CcSEcCtD
Nelfinavir—Arthritis—Capecitabine—esophageal cancer	0.000529	0.00763	CcSEcCtD
Nelfinavir—Stomatitis—Cisplatin—esophageal cancer	0.000524	0.00756	CcSEcCtD
Nelfinavir—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000514	0.00742	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000508	0.00733	CcSEcCtD
Nelfinavir—Migraine—Capecitabine—esophageal cancer	0.000506	0.0073	CcSEcCtD
Nelfinavir—Mood swings—Capecitabine—esophageal cancer	0.000487	0.00703	CcSEcCtD
Nelfinavir—Dehydration—Capecitabine—esophageal cancer	0.000478	0.0069	CcSEcCtD
Nelfinavir—Mouth ulceration—Methotrexate—esophageal cancer	0.000477	0.00688	CcSEcCtD
Nelfinavir—Liver function test abnormal—Capecitabine—esophageal cancer	0.000475	0.00685	CcSEcCtD
Nelfinavir—Connective tissue disorder—Cisplatin—esophageal cancer	0.000474	0.00684	CcSEcCtD
Nelfinavir—Abdominal pain upper—Capecitabine—esophageal cancer	0.00047	0.00677	CcSEcCtD
Nelfinavir—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000463	0.00668	CcSEcCtD
Nelfinavir—Muscular weakness—Capecitabine—esophageal cancer	0.000453	0.00654	CcSEcCtD
Nelfinavir—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000453	0.00654	CcSEcCtD
Nelfinavir—Eye disorder—Cisplatin—esophageal cancer	0.000451	0.00651	CcSEcCtD
Nelfinavir—Abdominal distension—Capecitabine—esophageal cancer	0.000447	0.00645	CcSEcCtD
Nelfinavir—Diabetes mellitus—Methotrexate—esophageal cancer	0.00044	0.00635	CcSEcCtD
Nelfinavir—Bronchospasm—Capecitabine—esophageal cancer	0.000437	0.00631	CcSEcCtD
Nelfinavir—Immune system disorder—Cisplatin—esophageal cancer	0.000436	0.00629	CcSEcCtD
Nelfinavir—Malnutrition—Cisplatin—esophageal cancer	0.00042	0.00606	CcSEcCtD
Nelfinavir—Erythema—Cisplatin—esophageal cancer	0.00042	0.00606	CcSEcCtD
Nelfinavir—Neutropenia—Capecitabine—esophageal cancer	0.000415	0.00599	CcSEcCtD
Nelfinavir—Flatulence—Cisplatin—esophageal cancer	0.000414	0.00597	CcSEcCtD
Nelfinavir—Muscle spasms—Cisplatin—esophageal cancer	0.000404	0.00583	CcSEcCtD
Nelfinavir—Hyperglycaemia—Capecitabine—esophageal cancer	0.000401	0.00578	CcSEcCtD
Nelfinavir—Pneumonia—Capecitabine—esophageal cancer	0.000398	0.00575	CcSEcCtD
Nelfinavir—Ill-defined disorder—Cisplatin—esophageal cancer	0.00039	0.00562	CcSEcCtD
Nelfinavir—Anaemia—Cisplatin—esophageal cancer	0.000388	0.0056	CcSEcCtD
Nelfinavir—Stomatitis—Capecitabine—esophageal cancer	0.000386	0.00557	CcSEcCtD
Nelfinavir—Jaundice—Capecitabine—esophageal cancer	0.000386	0.00557	CcSEcCtD
Nelfinavir—Malaise—Cisplatin—esophageal cancer	0.000379	0.00546	CcSEcCtD
Nelfinavir—Leukopenia—Cisplatin—esophageal cancer	0.000376	0.00542	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000375	0.00541	CcSEcCtD
Nelfinavir—Epistaxis—Capecitabine—esophageal cancer	0.000374	0.00539	CcSEcCtD
Nelfinavir—Convulsion—Cisplatin—esophageal cancer	0.000364	0.00525	CcSEcCtD
Nelfinavir—Mood swings—Methotrexate—esophageal cancer	0.000363	0.00523	CcSEcCtD
Nelfinavir—Myalgia—Cisplatin—esophageal cancer	0.000358	0.00516	CcSEcCtD
Nelfinavir—Haemoglobin—Capecitabine—esophageal cancer	0.000357	0.00516	CcSEcCtD
Nelfinavir—Rhinitis—Capecitabine—esophageal cancer	0.000357	0.00514	CcSEcCtD
Nelfinavir—Anxiety—Cisplatin—esophageal cancer	0.000356	0.00514	CcSEcCtD
Nelfinavir—Haemorrhage—Capecitabine—esophageal cancer	0.000356	0.00513	CcSEcCtD
Nelfinavir—Hepatitis—Capecitabine—esophageal cancer	0.000356	0.00513	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000355	0.00512	CcSEcCtD
Nelfinavir—Liver function test abnormal—Methotrexate—esophageal cancer	0.000353	0.0051	CcSEcCtD
Nelfinavir—Discomfort—Cisplatin—esophageal cancer	0.000353	0.0051	CcSEcCtD
Nelfinavir—Pharyngitis—Capecitabine—esophageal cancer	0.000353	0.00509	CcSEcCtD
Nelfinavir—Connective tissue disorder—Capecitabine—esophageal cancer	0.000349	0.00504	CcSEcCtD
Nelfinavir—Oedema—Cisplatin—esophageal cancer	0.000343	0.00495	CcSEcCtD
Nelfinavir—Erythema multiforme—Capecitabine—esophageal cancer	0.000336	0.00485	CcSEcCtD
Nelfinavir—Thrombocytopenia—Cisplatin—esophageal cancer	0.000336	0.00484	CcSEcCtD
Nelfinavir—Skin disorder—Cisplatin—esophageal cancer	0.000333	0.0048	CcSEcCtD
Nelfinavir—Eye disorder—Capecitabine—esophageal cancer	0.000332	0.0048	CcSEcCtD
Nelfinavir—Hyperhidrosis—Cisplatin—esophageal cancer	0.000331	0.00478	CcSEcCtD
Nelfinavir—Anorexia—Cisplatin—esophageal cancer	0.000327	0.00471	CcSEcCtD
Nelfinavir—Pancreatitis—Methotrexate—esophageal cancer	0.000324	0.00468	CcSEcCtD
Nelfinavir—Angiopathy—Capecitabine—esophageal cancer	0.000323	0.00466	CcSEcCtD
Nelfinavir—Immune system disorder—Capecitabine—esophageal cancer	0.000321	0.00463	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000312	0.00451	CcSEcCtD
Nelfinavir—Malnutrition—Capecitabine—esophageal cancer	0.00031	0.00447	CcSEcCtD
Nelfinavir—Erythema—Capecitabine—esophageal cancer	0.00031	0.00447	CcSEcCtD
Nelfinavir—Neutropenia—Methotrexate—esophageal cancer	0.000309	0.00446	CcSEcCtD
Nelfinavir—Paraesthesia—Cisplatin—esophageal cancer	0.000308	0.00444	CcSEcCtD
Nelfinavir—Dyspnoea—Cisplatin—esophageal cancer	0.000306	0.00441	CcSEcCtD
Nelfinavir—Flatulence—Capecitabine—esophageal cancer	0.000305	0.0044	CcSEcCtD
Nelfinavir—Back pain—Capecitabine—esophageal cancer	0.000299	0.00432	CcSEcCtD
Nelfinavir—Decreased appetite—Cisplatin—esophageal cancer	0.000298	0.0043	CcSEcCtD
Nelfinavir—Muscle spasms—Capecitabine—esophageal cancer	0.000298	0.00429	CcSEcCtD
Nelfinavir—Pneumonia—Methotrexate—esophageal cancer	0.000297	0.00428	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000296	0.00427	CcSEcCtD
Nelfinavir—Pain—Cisplatin—esophageal cancer	0.000293	0.00423	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—esophageal cancer	0.000287	0.00415	CcSEcCtD
Nelfinavir—Ill-defined disorder—Capecitabine—esophageal cancer	0.000287	0.00414	CcSEcCtD
Nelfinavir—Anaemia—Capecitabine—esophageal cancer	0.000286	0.00413	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—esophageal cancer	0.000283	0.00408	CcSEcCtD
Nelfinavir—Feeling abnormal—Cisplatin—esophageal cancer	0.000282	0.00408	CcSEcCtD
Nelfinavir—Malaise—Capecitabine—esophageal cancer	0.000279	0.00403	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000279	0.00402	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—esophageal cancer	0.000278	0.00401	CcSEcCtD
Nelfinavir—Leukopenia—Capecitabine—esophageal cancer	0.000277	0.004	CcSEcCtD
Nelfinavir—Body temperature increased—Cisplatin—esophageal cancer	0.000271	0.00391	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—esophageal cancer	0.000266	0.00384	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—esophageal cancer	0.000265	0.00382	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—esophageal cancer	0.000265	0.00382	CcSEcCtD
Nelfinavir—Myalgia—Capecitabine—esophageal cancer	0.000264	0.0038	CcSEcCtD
Nelfinavir—Arthralgia—Capecitabine—esophageal cancer	0.000264	0.0038	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—esophageal cancer	0.000263	0.00379	CcSEcCtD
Nelfinavir—Anxiety—Capecitabine—esophageal cancer	0.000263	0.00379	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000262	0.00378	CcSEcCtD
Nelfinavir—Discomfort—Capecitabine—esophageal cancer	0.00026	0.00376	CcSEcCtD
Nelfinavir—Oedema—Capecitabine—esophageal cancer	0.000253	0.00365	CcSEcCtD
Nelfinavir—Hypersensitivity—Cisplatin—esophageal cancer	0.000253	0.00364	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—esophageal cancer	0.00025	0.00361	CcSEcCtD
Nelfinavir—Eye disorder—Methotrexate—esophageal cancer	0.000247	0.00357	CcSEcCtD
Nelfinavir—Thrombocytopenia—Capecitabine—esophageal cancer	0.000247	0.00357	CcSEcCtD
Nelfinavir—Asthenia—Cisplatin—esophageal cancer	0.000246	0.00355	CcSEcCtD
Nelfinavir—Skin disorder—Capecitabine—esophageal cancer	0.000245	0.00354	CcSEcCtD
Nelfinavir—Hyperhidrosis—Capecitabine—esophageal cancer	0.000244	0.00352	CcSEcCtD
Nelfinavir—Anorexia—Capecitabine—esophageal cancer	0.000241	0.00347	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—esophageal cancer	0.00024	0.00347	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—esophageal cancer	0.000239	0.00345	CcSEcCtD
Nelfinavir—Diarrhoea—Cisplatin—esophageal cancer	0.000235	0.00338	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—esophageal cancer	0.00023	0.00333	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—esophageal cancer	0.00023	0.00333	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00023	0.00332	CcSEcCtD
Nelfinavir—Insomnia—Capecitabine—esophageal cancer	0.000229	0.0033	CcSEcCtD
Nelfinavir—Paraesthesia—Capecitabine—esophageal cancer	0.000227	0.00327	CcSEcCtD
Nelfinavir—Dyspnoea—Capecitabine—esophageal cancer	0.000225	0.00325	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—esophageal cancer	0.000223	0.00322	CcSEcCtD
Nelfinavir—Dyspepsia—Capecitabine—esophageal cancer	0.000222	0.00321	CcSEcCtD
Nelfinavir—Decreased appetite—Capecitabine—esophageal cancer	0.00022	0.00317	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000218	0.00315	CcSEcCtD
Nelfinavir—Vomiting—Cisplatin—esophageal cancer	0.000218	0.00314	CcSEcCtD
Nelfinavir—Rash—Cisplatin—esophageal cancer	0.000216	0.00312	CcSEcCtD
Nelfinavir—Pain—Capecitabine—esophageal cancer	0.000216	0.00312	CcSEcCtD
Nelfinavir—Dermatitis—Cisplatin—esophageal cancer	0.000216	0.00312	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—esophageal cancer	0.000214	0.00309	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—esophageal cancer	0.000213	0.00307	CcSEcCtD
Nelfinavir—Feeling abnormal—Capecitabine—esophageal cancer	0.000208	0.003	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—esophageal cancer	0.000208	0.003	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000207	0.00298	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—esophageal cancer	0.000206	0.00298	CcSEcCtD
Nelfinavir—Nausea—Cisplatin—esophageal cancer	0.000204	0.00294	CcSEcCtD
Nelfinavir—Urticaria—Capecitabine—esophageal cancer	0.000201	0.0029	CcSEcCtD
Nelfinavir—Abdominal pain—Capecitabine—esophageal cancer	0.0002	0.00288	CcSEcCtD
Nelfinavir—Body temperature increased—Capecitabine—esophageal cancer	0.0002	0.00288	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—esophageal cancer	0.0002	0.00288	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—esophageal cancer	0.000196	0.00283	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—esophageal cancer	0.000196	0.00283	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000195	0.00281	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—esophageal cancer	0.000194	0.0028	CcSEcCtD
Nelfinavir—Hypersensitivity—Capecitabine—esophageal cancer	0.000186	0.00269	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—esophageal cancer	0.000184	0.00266	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—esophageal cancer	0.000183	0.00264	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—esophageal cancer	0.000182	0.00262	CcSEcCtD
Nelfinavir—Asthenia—Capecitabine—esophageal cancer	0.000181	0.00262	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—esophageal cancer	0.000179	0.00259	CcSEcCtD
Nelfinavir—Pruritus—Capecitabine—esophageal cancer	0.000179	0.00258	CcSEcCtD
Nelfinavir—Diarrhoea—Capecitabine—esophageal cancer	0.000173	0.00249	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000171	0.00247	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—esophageal cancer	0.00017	0.00245	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—esophageal cancer	0.000169	0.00244	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—esophageal cancer	0.000168	0.00242	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—esophageal cancer	0.000167	0.00241	CcSEcCtD
Nelfinavir—Dizziness—Capecitabine—esophageal cancer	0.000167	0.00241	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—esophageal cancer	0.000166	0.00239	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—esophageal cancer	0.000164	0.00236	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000162	0.00234	CcSEcCtD
Nelfinavir—Pain—Methotrexate—esophageal cancer	0.000161	0.00232	CcSEcCtD
Nelfinavir—Vomiting—Capecitabine—esophageal cancer	0.000161	0.00232	CcSEcCtD
Nelfinavir—Rash—Capecitabine—esophageal cancer	0.000159	0.0023	CcSEcCtD
Nelfinavir—Dermatitis—Capecitabine—esophageal cancer	0.000159	0.0023	CcSEcCtD
Nelfinavir—Headache—Capecitabine—esophageal cancer	0.000158	0.00228	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—esophageal cancer	0.000155	0.00224	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000154	0.00222	CcSEcCtD
Nelfinavir—Nausea—Capecitabine—esophageal cancer	0.00015	0.00217	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—esophageal cancer	0.000149	0.00216	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—esophageal cancer	0.000149	0.00215	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—esophageal cancer	0.000149	0.00215	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—esophageal cancer	0.000139	0.002	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—esophageal cancer	0.000135	0.00195	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—esophageal cancer	0.000133	0.00192	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—esophageal cancer	0.000129	0.00186	CcSEcCtD
Nelfinavir—Dizziness—Methotrexate—esophageal cancer	0.000124	0.00179	CcSEcCtD
Nelfinavir—Vomiting—Methotrexate—esophageal cancer	0.00012	0.00173	CcSEcCtD
Nelfinavir—Rash—Methotrexate—esophageal cancer	0.000119	0.00171	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—esophageal cancer	0.000118	0.00171	CcSEcCtD
Nelfinavir—Headache—Methotrexate—esophageal cancer	0.000118	0.0017	CcSEcCtD
Nelfinavir—Nausea—Methotrexate—esophageal cancer	0.000112	0.00161	CcSEcCtD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.08e-05	0.000143	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—TYMP—esophageal cancer	2.07e-05	0.000142	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ALDH2—esophageal cancer	2.07e-05	0.000142	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP26A1—esophageal cancer	2.07e-05	0.000142	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.04e-05	0.00014	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.03e-05	0.00014	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.03e-05	0.000139	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ALDH2—esophageal cancer	2.02e-05	0.000139	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.02e-05	0.000139	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CYP19A1—esophageal cancer	2.01e-05	0.000138	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALOX15—esophageal cancer	2.01e-05	0.000138	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CYP19A1—esophageal cancer	2e-05	0.000137	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.99e-05	0.000137	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—HMOX1—esophageal cancer	1.98e-05	0.000136	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP1B1—esophageal cancer	1.98e-05	0.000136	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PLCE1—esophageal cancer	1.97e-05	0.000136	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ADH7—esophageal cancer	1.97e-05	0.000136	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—GSTT1—esophageal cancer	1.97e-05	0.000135	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALOX15—esophageal cancer	1.96e-05	0.000135	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—TYMP—esophageal cancer	1.95e-05	0.000134	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	1.95e-05	0.000134	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP2A6—esophageal cancer	1.95e-05	0.000134	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.95e-05	0.000134	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—TYMP—esophageal cancer	1.94e-05	0.000133	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—GSTT1—esophageal cancer	1.93e-05	0.000132	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTO1—esophageal cancer	1.92e-05	0.000132	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—TPI1—esophageal cancer	1.92e-05	0.000132	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—ABCB1—esophageal cancer	1.9e-05	0.000131	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP2A6—esophageal cancer	1.9e-05	0.000131	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP26A1—esophageal cancer	1.9e-05	0.000131	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.88e-05	0.000129	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTO1—esophageal cancer	1.87e-05	0.000129	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—TPI1—esophageal cancer	1.87e-05	0.000129	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CYP19A1—esophageal cancer	1.86e-05	0.000128	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALOX15—esophageal cancer	1.85e-05	0.000127	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTGS1—esophageal cancer	1.85e-05	0.000127	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ENO1—esophageal cancer	1.85e-05	0.000127	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALDOB—esophageal cancer	1.84e-05	0.000127	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—HMOX1—esophageal cancer	1.84e-05	0.000126	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.84e-05	0.000126	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—HMOX1—esophageal cancer	1.82e-05	0.000125	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PSME1—esophageal cancer	1.82e-05	0.000125	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PSME2—esophageal cancer	1.82e-05	0.000125	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ENO1—esophageal cancer	1.8e-05	0.000124	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTGS1—esophageal cancer	1.8e-05	0.000124	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALDOB—esophageal cancer	1.8e-05	0.000124	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.79e-05	0.000123	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CA1—esophageal cancer	1.79e-05	0.000123	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PSME2—esophageal cancer	1.78e-05	0.000122	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PSME1—esophageal cancer	1.78e-05	0.000122	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GAPDH—esophageal cancer	1.77e-05	0.000122	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—TPI1—esophageal cancer	1.77e-05	0.000121	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTO1—esophageal cancer	1.77e-05	0.000121	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—ABCB1—esophageal cancer	1.76e-05	0.000121	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CRABP1—esophageal cancer	1.76e-05	0.000121	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.75e-05	0.00012	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—TPI1—esophageal cancer	1.75e-05	0.00012	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—ABCB1—esophageal cancer	1.75e-05	0.00012	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ADH1B—esophageal cancer	1.73e-05	0.000119	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GAPDH—esophageal cancer	1.73e-05	0.000119	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.73e-05	0.000119	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CRABP1—esophageal cancer	1.71e-05	0.000118	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—HMOX1—esophageal cancer	1.69e-05	0.000117	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALDOB—esophageal cancer	1.69e-05	0.000116	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.68e-05	0.000116	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.68e-05	0.000115	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GNG7—esophageal cancer	1.67e-05	0.000115	CbGpPWpGaD
Nelfinavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.67e-05	0.000115	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TYMP—esophageal cancer	1.65e-05	0.000114	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CA2—esophageal cancer	1.64e-05	0.000113	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GNG7—esophageal cancer	1.63e-05	0.000112	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GAPDH—esophageal cancer	1.63e-05	0.000112	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—ABCB1—esophageal cancer	1.63e-05	0.000112	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.62e-05	0.000111	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CRABP1—esophageal cancer	1.62e-05	0.000111	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP26A1—esophageal cancer	1.61e-05	0.000111	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.6e-05	0.00011	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP1B1—esophageal cancer	1.57e-05	0.000108	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALOX15—esophageal cancer	1.57e-05	0.000108	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ALDH2—esophageal cancer	1.57e-05	0.000108	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GNG7—esophageal cancer	1.54e-05	0.000106	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP1B1—esophageal cancer	1.53e-05	0.000106	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ALDH2—esophageal cancer	1.53e-05	0.000105	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ADH7—esophageal cancer	1.52e-05	0.000105	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.52e-05	0.000105	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GNG7—esophageal cancer	1.52e-05	0.000105	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTO1—esophageal cancer	1.5e-05	0.000103	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—TPI1—esophageal cancer	1.5e-05	0.000103	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—GSTT1—esophageal cancer	1.49e-05	0.000102	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—CREBBP—esophageal cancer	1.49e-05	0.000102	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CYP19A1—esophageal cancer	1.48e-05	0.000101	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP2A6—esophageal cancer	1.47e-05	0.000101	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.47e-05	0.000101	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—GSTT1—esophageal cancer	1.45e-05	9.99e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CYP19A1—esophageal cancer	1.44e-05	9.92e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.44e-05	9.9e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ALDH2—esophageal cancer	1.44e-05	9.9e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.44e-05	9.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALDOB—esophageal cancer	1.43e-05	9.86e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.43e-05	9.81e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTGS1—esophageal cancer	1.39e-05	9.59e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ENO1—esophageal cancer	1.39e-05	9.59e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GAPDH—esophageal cancer	1.38e-05	9.49e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PSME1—esophageal cancer	1.37e-05	9.45e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PSME2—esophageal cancer	1.37e-05	9.45e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.37e-05	9.42e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CRABP1—esophageal cancer	1.37e-05	9.41e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—ENO1—esophageal cancer	1.36e-05	9.36e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTGS1—esophageal cancer	1.36e-05	9.36e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.36e-05	9.35e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.36e-05	9.33e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.35e-05	9.31e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—HMOX1—esophageal cancer	1.35e-05	9.26e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.34e-05	9.23e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PSME2—esophageal cancer	1.34e-05	9.23e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PSME1—esophageal cancer	1.34e-05	9.23e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.34e-05	9.19e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.34e-05	9.19e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—NOS3—esophageal cancer	1.33e-05	9.16e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—HMOX1—esophageal cancer	1.32e-05	9.05e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GNG7—esophageal cancer	1.3e-05	8.95e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—ABCB1—esophageal cancer	1.29e-05	8.89e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ENO1—esophageal cancer	1.28e-05	8.82e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.28e-05	8.82e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TYMP—esophageal cancer	1.28e-05	8.78e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—CREBBP—esophageal cancer	1.27e-05	8.75e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ENO1—esophageal cancer	1.27e-05	8.75e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.27e-05	8.75e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PSME1—esophageal cancer	1.26e-05	8.69e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PSME2—esophageal cancer	1.26e-05	8.69e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—ABCB1—esophageal cancer	1.26e-05	8.69e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PSME2—esophageal cancer	1.25e-05	8.62e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PSME1—esophageal cancer	1.25e-05	8.62e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.24e-05	8.54e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ALDH2—esophageal cancer	1.22e-05	8.39e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PTGS2—esophageal cancer	1.22e-05	8.38e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.21e-05	8.32e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.2e-05	8.25e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP1B1—esophageal cancer	1.19e-05	8.16e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—CREBBP—esophageal cancer	1.18e-05	8.1e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—CREBBP—esophageal cancer	1.17e-05	8.03e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—GSTT1—esophageal cancer	1.16e-05	7.98e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.16e-05	7.96e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—TPI1—esophageal cancer	1.15e-05	7.94e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.15e-05	7.94e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP2A6—esophageal cancer	1.15e-05	7.88e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.14e-05	7.85e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—NOS3—esophageal cancer	1.14e-05	7.84e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CYP19A1—esophageal cancer	1.12e-05	7.67e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.11e-05	7.61e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.09e-05	7.53e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.09e-05	7.5e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.09e-05	7.48e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—CREBBP—esophageal cancer	1.09e-05	7.48e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTGS1—esophageal cancer	1.09e-05	7.47e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ENO1—esophageal cancer	1.09e-05	7.47e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.08e-05	7.44e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PSME2—esophageal cancer	1.07e-05	7.37e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PSME1—esophageal cancer	1.07e-05	7.37e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.07e-05	7.33e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.06e-05	7.26e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—NOS3—esophageal cancer	1.06e-05	7.26e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—NOS3—esophageal cancer	1.05e-05	7.19e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PTGS2—esophageal cancer	1.04e-05	7.17e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.03e-05	7.05e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—HMOX1—esophageal cancer	1.02e-05	7e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.02e-05	6.99e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—EP300—esophageal cancer	1.01e-05	6.97e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GNG7—esophageal cancer	1e-05	6.91e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.98e-06	6.87e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—HMOX1—esophageal cancer	9.93e-06	6.83e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—ABCB1—esophageal cancer	9.77e-06	6.72e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—NOS3—esophageal cancer	9.73e-06	6.69e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PTGS2—esophageal cancer	9.65e-06	6.64e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PTGS2—esophageal cancer	9.57e-06	6.58e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ALDH2—esophageal cancer	9.41e-06	6.47e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—HMOX1—esophageal cancer	9.36e-06	6.44e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	9.35e-06	6.43e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—HMOX1—esophageal cancer	9.28e-06	6.38e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP1B1—esophageal cancer	9.24e-06	6.36e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.1e-06	6.26e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—ABCB1—esophageal cancer	8.98e-06	6.18e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—GSTT1—esophageal cancer	8.95e-06	6.16e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—ABCB1—esophageal cancer	8.91e-06	6.12e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PTGS2—esophageal cancer	8.9e-06	6.12e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP2A6—esophageal cancer	8.85e-06	6.08e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CYP19A1—esophageal cancer	8.69e-06	5.98e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—EP300—esophageal cancer	8.67e-06	5.96e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—CREBBP—esophageal cancer	8.64e-06	5.94e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—CREBBP—esophageal cancer	8.44e-06	5.81e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ENO1—esophageal cancer	8.39e-06	5.77e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTGS1—esophageal cancer	8.39e-06	5.77e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PSME1—esophageal cancer	8.27e-06	5.68e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PSME2—esophageal cancer	8.27e-06	5.68e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—EP300—esophageal cancer	8.03e-06	5.52e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—EP300—esophageal cancer	7.96e-06	5.47e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—HMOX1—esophageal cancer	7.93e-06	5.45e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.78e-06	5.35e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—NOS3—esophageal cancer	7.73e-06	5.32e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—ABCB1—esophageal cancer	7.61e-06	5.23e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—NOS3—esophageal cancer	7.56e-06	5.2e-05	CbGpPWpGaD
Nelfinavir—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	7.5e-06	5.16e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—EP300—esophageal cancer	7.4e-06	5.09e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.38e-06	5.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7.13e-06	4.9e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PTGS2—esophageal cancer	7.07e-06	4.86e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PTGS2—esophageal cancer	6.91e-06	4.75e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.73e-06	4.63e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CYP19A1—esophageal cancer	6.71e-06	4.61e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—CREBBP—esophageal cancer	6.53e-06	4.49e-05	CbGpPWpGaD
Nelfinavir—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	6.41e-06	4.41e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—CREBBP—esophageal cancer	6.37e-06	4.38e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—HMOX1—esophageal cancer	6.12e-06	4.21e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—CREBBP—esophageal cancer	6e-06	4.13e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—CREBBP—esophageal cancer	5.95e-06	4.09e-05	CbGpPWpGaD
Nelfinavir—ABCG2—Metabolism—PIK3CA—esophageal cancer	5.94e-06	4.08e-05	CbGpPWpGaD
Nelfinavir—CYP3A7—Metabolism—PIK3CA—esophageal cancer	5.89e-06	4.05e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—EP300—esophageal cancer	5.88e-06	4.05e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—ABCB1—esophageal cancer	5.87e-06	4.04e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—NOS3—esophageal cancer	5.84e-06	4.02e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.75e-06	3.96e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—EP300—esophageal cancer	5.75e-06	3.95e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—NOS3—esophageal cancer	5.7e-06	3.92e-05	CbGpPWpGaD
Nelfinavir—SLC22A1—Metabolism—PIK3CA—esophageal cancer	5.48e-06	3.77e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—NOS3—esophageal cancer	5.38e-06	3.7e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PTGS2—esophageal cancer	5.35e-06	3.68e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—NOS3—esophageal cancer	5.33e-06	3.66e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PTGS2—esophageal cancer	5.22e-06	3.59e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—CREBBP—esophageal cancer	5.09e-06	3.5e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PTGS2—esophageal cancer	4.92e-06	3.38e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.87e-06	3.35e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—NOS3—esophageal cancer	4.55e-06	3.13e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—EP300—esophageal cancer	4.45e-06	3.06e-05	CbGpPWpGaD
Nelfinavir—CYP2B6—Metabolism—PIK3CA—esophageal cancer	4.35e-06	2.99e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—EP300—esophageal cancer	4.34e-06	2.98e-05	CbGpPWpGaD
Nelfinavir—CYP3A5—Metabolism—PIK3CA—esophageal cancer	4.25e-06	2.93e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PTGS2—esophageal cancer	4.17e-06	2.86e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—EP300—esophageal cancer	4.09e-06	2.81e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—EP300—esophageal cancer	4.05e-06	2.79e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—CREBBP—esophageal cancer	3.93e-06	2.7e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—NOS3—esophageal cancer	3.51e-06	2.42e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—EP300—esophageal cancer	3.46e-06	2.38e-05	CbGpPWpGaD
Nelfinavir—CYP2C19—Metabolism—PIK3CA—esophageal cancer	3.29e-06	2.26e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.21e-06	2.21e-05	CbGpPWpGaD
Nelfinavir—ABCB1—Metabolism—PIK3CA—esophageal cancer	3.21e-06	2.21e-05	CbGpPWpGaD
Nelfinavir—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.02e-06	2.08e-05	CbGpPWpGaD
Nelfinavir—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3e-06	2.06e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—EP300—esophageal cancer	2.67e-06	1.84e-05	CbGpPWpGaD
Nelfinavir—CYP1A2—Metabolism—PIK3CA—esophageal cancer	2.56e-06	1.76e-05	CbGpPWpGaD
Nelfinavir—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.98e-06	1.36e-05	CbGpPWpGaD
